Suchergebnisse - "HUI AI-MIN"

PubPharm (122)

1

Model-informed dose selection for an investigational human epidermal growth factor receptor 2 antibody-drug conjugate FS-1502 in patients with human epidermal growth factor receptor 2-expressing advanced malignant solid tumours

enthalten in: British journal of clinical pharmacology | 2024

von Sun, Y. | Li, C. | Wang, X. | +4

2

Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers : A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study

enthalten in: International journal of clinical practice | 2024

von Yuan, G. | Chen, Y. | Li, L. | +10

3

Model‐informed dose selection for an investigational human epidermal growth factor receptor 2 antibody–drug conjugate FS‐1502 in patients with human epidermal growth factor receptor 2‐expressing advanced malignant solid tumours

enthalten in: British Journal of Clinical Pharmacology | 2024

von Sun, Y. | Li, C. | Wang, X. | +4

4

Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults

enthalten in: Drugs in R&D | 2023

von Qin, H. | Tan, Y. | Diao, L. | +7

5

Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults

enthalten in: Drugs in R & D | 2023

von Qin, H. | Tan, Y. | Diao, L. | +7

6

Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas

enthalten in: BMC medicine | 2023

von Hu, X. | Li, W. | Zeng, K. | +14

7

Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas

enthalten in: BMC medicine | 2023

von Hu, X. | Li, W. | Zeng, K. | +14

8

Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas

enthalten in: BMC medicine | 2023

von Hu, X. | Li, W. | Zeng, K. | +14

9

Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males

enthalten in: Advances in therapy | 2023

von Li, J. | Tan, Y. | Li, K. | +7

10

Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males

enthalten in: Advances in therapy | 2023

von Li, J. | Tan, Y. | Li, K. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]